Transcept Pharma Enters Oversold Territory – Tale of the Tape

Transcept Pharmaceuticals, Inc. ’s (TSPT) share price has entered into oversold territory with a stochastic value of 17.716. The Zacks Consensus Estimate on the company’s earnings for year ending December 2011 increased by 46 cents over the past two months to 95 cents per share. Transcept Pharmaceuticals is a Zacks #1 Rank (“Strong Buy”) company.